Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

One year effectiveness study of intravitreal aflibercept in neovascular age-related macular degeneration: a meta-analysis.

Guo MY, Cheng J, Etminan M, Zafari Z, Maberley D.

Acta Ophthalmol. 2018 Jul 21. doi: 10.1111/aos.13825. [Epub ahead of print] Review.

PMID:
30030923
2.

Statin medications and the risk of gynecomastia.

Skeldon SC, Carleton B, Brophy JM, Sodhi M, Etminan M.

Clin Endocrinol (Oxf). 2018 Jun 19. doi: 10.1111/cen.13794. [Epub ahead of print]

PMID:
29923212
3.

Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.

Guo MY, Etminan M, Procyshyn RM, Kim DD, Samii A, Kezouh A, Carleton BC.

J Clin Psychopharmacol. 2018 Aug;38(4):349-356. doi: 10.1097/JCP.0000000000000911.

PMID:
29901567
4.

Oral Fluoroquinolone Prescribing to Children in the United States From 2006 to 2015.

Etminan M, Guo M, Carleton B.

Pediatr Infect Dis J. 2018 May 24. doi: 10.1097/INF.0000000000002121. [Epub ahead of print]

PMID:
29846302
5.

Improving Reporting Quality in Ophthalmologic Observational Studies That Use Big Data: The Case of Retinal Detachment Associated With Fluoroquinolone Use.

Etminan M, Maberley DAL.

JAMA Ophthalmol. 2018 Jun 1;136(6):611-612. doi: 10.1001/jamaophthalmol.2018.0987. No abstract available.

PMID:
29710207
6.

Risk of Anterior Segment Complications Associated With the Live Herpes Zoster Vaccine: Evidence From a Health-Claim Database.

Liu RT, Yeung SN, Carleton B, Etminan M.

Cornea. 2018 Aug;37(8):952-956. doi: 10.1097/ICO.0000000000001595.

PMID:
29601366
7.

Association of Postoperative Topical Prostaglandin Analog or Beta-Blocker Use and Incidence of Pseudophakic Cystoid Macular Edema.

Wendel C, Zakrzewski H, Carleton B, Etminan M, Mikelberg FS.

J Glaucoma. 2018 May;27(5):402-406. doi: 10.1097/IJG.0000000000000929.

PMID:
29505438
8.

Dentists’ Prescribing of Analgesics for Children in British Columbia, Canada

Etminan M, Nouri MR, Sodhi M, Carleton BC.

J Can Dent Assoc. 2017 Aug;83:h5.

9.

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology.

Sadatsafavi M, Xie H, Etminan M, Johnson K, FitzGerald JM; Canadian Respiratory Research Network.

PLoS One. 2018 Jan 19;13(1):e0191243. doi: 10.1371/journal.pone.0191243. eCollection 2018.

10.

One-Year Effectiveness Study of Intravitreous Ranibizumab in Wet (Neovascular) Age-Related Macular Degeneration: A Meta-Analysis.

Guo MY, Etminan M, Cheng JZ, Zafari Z, Maberley DAL.

Pharmacotherapy. 2018 Feb;38(2):197-204. doi: 10.1002/phar.2079.

PMID:
29286545
11.

Handling time varying confounding in observational research.

Mansournia MA, Etminan M, Danaei G, Kaufman JS, Collins G.

BMJ. 2017 Oct 16;359:j4587. doi: 10.1136/bmj.j4587. Review. No abstract available.

PMID:
29038130
12.

Revised disproportionality analysis of Mirena and benign intracranial hypertension.

Etminan M.

Ther Adv Drug Saf. 2017 Sep;8(9):299-300. doi: 10.1177/2042098617709768. Epub 2017 Jun 22. No abstract available.

13.

Risk of hair loss with different antidepressants: a comparative retrospective cohort study.

Etminan M, Sodhi M, Procyshyn RM, Guo M, Carleton BC.

Int Clin Psychopharmacol. 2018 Jan;33(1):44-48. doi: 10.1097/YIC.0000000000000191.

PMID:
28763345
14.

Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: Nested case-control study.

Sodhi M, Sheldon CA, Carleton B, Etminan M.

Neurology. 2017 Aug 22;89(8):792-795. doi: 10.1212/WNL.0000000000004247. Epub 2017 Jul 28.

PMID:
28754842
15.

Fluoroquinolone Use and Risk of Carpal Tunnel Syndrome: A Pharmacoepidemiologic Study.

Cheng JZ, Sodhi M, Etminan M, Carleton BC.

Clin Infect Dis. 2017 Aug 15;65(4):684-686. doi: 10.1093/cid/cix362.

PMID:
28444196
16.

Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery.

Eadie BD, Etminan M, Carleton BC, Maberley DA, Mikelberg FS.

JAMA Ophthalmol. 2017 Apr 1;135(4):363-368. doi: 10.1001/jamaophthalmol.2017.0059.

17.

Reply.

Mammo Z, Guo M, Maberley D, Matsubara J, Etminan M.

Am J Ophthalmol. 2017 Apr;176:255-256. doi: 10.1016/j.ajo.2017.01.009. Epub 2017 Feb 9. No abstract available.

PMID:
28190509
18.

Risk of intraocular hemorrhage with new oral anticoagulants.

Talany G, Guo M, Etminan M.

Eye (Lond). 2017 Apr;31(4):628-631. doi: 10.1038/eye.2016.265. Epub 2016 Dec 23.

19.

Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.

Etminan M, Sodhi M, Samii A, Procyshyn RM, Guo M, Carleton BC.

J Clin Psychopharmacol. 2017 Feb;37(1):102-104. doi: 10.1097/JCP.0000000000000634.

PMID:
27930495
20.

Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss.

Guo M, Heran B, Flannigan R, Kezouh A, Etminan M.

Pharmacotherapy. 2016 Nov;36(11):1180-1184. doi: 10.1002/phar.1837. Epub 2016 Oct 20.

PMID:
27644029
21.

Risk of Extrapyramidal Adverse Events With Aripiprazole.

Etminan M, Procyshyn RM, Samii A, Carleton BC.

J Clin Psychopharmacol. 2016 Oct;36(5):472-4. doi: 10.1097/JCP.0000000000000543.

PMID:
27580493
22.

Risk of sensorineural hearing loss with macrolide antibiotics: A nested case-control study.

Etminan M, Westerberg BD, Kozak FK, Guo MY, Carleton BC.

Laryngoscope. 2017 Jan;127(1):229-232. doi: 10.1002/lary.26190. Epub 2016 Aug 6.

PMID:
27497265
23.

Oral Bisphosphonates and Risk of Wet Age-Related Macular Degeneration.

Mammo Z, Guo M, Maberley D, Matsubara J, Etminan M.

Am J Ophthalmol. 2016 Aug;168:62-67. doi: 10.1016/j.ajo.2016.04.022. Epub 2016 May 7.

PMID:
27163238
24.

Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration.

Etminan M, Maberley DA, Babiuk DW, Carleton BC.

Am J Ophthalmol. 2016 Jun;166:205. doi: 10.1016/j.ajo.2016.03.026. Epub 2016 Apr 16. No abstract available.

PMID:
27093892
25.

The Risk of Glioblastoma with TNF Inhibitors.

Guo M, Luo H, Samii A, Etminan M.

Pharmacotherapy. 2016 Apr;36(4):449-54. doi: 10.1002/phar.1731. Epub 2016 Apr 13. Erratum in: Pharmacotherapy. 2016 Jul;36(7):831.

PMID:
26931498
26.

Risk of intracranial hypertension with intrauterine levonorgestrel: reply.

Etminan M.

Ther Adv Drug Saf. 2016 Feb;7(1):25-6. doi: 10.1177/2042098615621264. No abstract available.

27.

Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration.

Etminan M, Maberley DA, Babiuk DW, Carleton BC.

Am J Ophthalmol. 2016 Mar;163:53-58. doi: 10.1016/j.ajo.2015.11.030. Epub 2015 Dec 15.

PMID:
26701272
28.

Risperidone and Risk of Gynecomastia in Young Men.

Etminan M, Carleton B, Brophy JM.

J Child Adolesc Psychopharmacol. 2015 Nov;25(9):671-3. doi: 10.1089/cap.2015.0024. Epub 2015 Aug 19.

PMID:
26287371
29.

Risk of intracranial hypertension with intrauterine levonorgestrel.

Etminan M, Luo H, Gustafson P.

Ther Adv Drug Saf. 2015 Jun;6(3):110-3. doi: 10.1177/2042098615588084.

30.

Risk of angle-closure glaucoma with bupropion and topiramate.

Symes RJ, Etminan M, Mikelberg FS.

JAMA Ophthalmol. 2015 Oct;133(10):1187-9. doi: 10.1001/jamaophthalmol.2015.2180.

PMID:
26158444
31.

Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study.

Ali AK, Heran BS, Etminan M.

Pharmacotherapy. 2015 Jul;35(7):687-95. doi: 10.1002/phar.1612. Epub 2015 Jul 1.

PMID:
26133534
32.

Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study.

Etminan M, Skeldon SC, Goldenberg SL, Carleton B, Brophy JM.

Pharmacotherapy. 2015 Jan;35(1):72-8. doi: 10.1002/phar.1534. Epub 2015 Jan 13.

PMID:
25582846
33.

Statin use and risk for cataract: a nested case-control study of 2 populations in Canada and the United States.

Wise SJ, Nathoo NA, Etminan M, Mikelberg FS, Mancini GB.

Can J Cardiol. 2014 Dec;30(12):1613-9. doi: 10.1016/j.cjca.2014.08.020.

PMID:
25475465
34.

Antibiotics and sudden death in adults taking renin-angiotensin system blockers.

Etminan M, Brophy JM.

BMJ. 2014 Oct 30;349:g6242. doi: 10.1136/bmj.g6242. No abstract available.

PMID:
25360034
35.

Association between phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy.

Nathoo NA, Etminan M, Mikelberg FS.

J Neuroophthalmol. 2015 Mar;35(1):12-5. doi: 10.1097/WNO.0000000000000186.

PMID:
25295683
36.

Risk for uveitis with oral moxifloxacin: a comparative safety study.

Eadie B, Etminan M, Mikelberg FS.

JAMA Ophthalmol. 2015 Jan;133(1):81-4. doi: 10.1001/jamaophthalmol.2014.3598.

PMID:
25275293
37.

Reporting guidelines for pharmacoepidemiological studies are urgently needed.

Etminan M.

BMJ. 2014 Sep 17;349:g5511. doi: 10.1136/bmj.g5511. No abstract available.

PMID:
25231185
38.

Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study.

Etminan M, Brophy JM, Samii A.

Neurology. 2014 Sep 30;83(14):1261-3. doi: 10.1212/WNL.0000000000000846. Epub 2014 Aug 22.

PMID:
25150290
39.

Risperidone use and risk for gynecomastia in men.

Etminan M, Heran B, Carleton B, Brophy JM.

J Clin Psychopharmacol. 2014 Oct;34(5):656-7. doi: 10.1097/JCP.0000000000000182. No abstract available.

PMID:
25006814
40.

Comparative effectiveness of olmesartan and other angiotensin receptor blockers in diabetes mellitus: retrospective cohort study.

Padwal R, Lin M, Etminan M, Eurich DT.

Hypertension. 2014 May;63(5):977-83. doi: 10.1161/HYPERTENSIONAHA.113.02855. Epub 2014 Feb 17.

41.

Reply: To PMID 24075430.

Pakzad-Vaezi KL, Etminan M, Mikelberg FS.

Am J Ophthalmol. 2014 Mar;157(3):747. doi: 10.1016/j.ajo.2013.12.007. No abstract available.

PMID:
24528938
42.
43.

The association between cataract surgery and atypical antipsychotic use: a nested case-control study.

Pakzad-Vaezi KL, Etminan M, Mikelberg FS.

Am J Ophthalmol. 2013 Dec;156(6):1141-1146.e1. doi: 10.1016/j.ajo.2013.07.012. Epub 2013 Sep 25.

PMID:
24075430
44.

Uveitis risk following oral fluoroquinolone therapy: a nested case-control Study.

Forooghian F, Maberley D, Albiani DA, Kirker AW, Merkur AB, Etminan M.

Ocul Immunol Inflamm. 2013 Oct;21(5):390-3. doi: 10.3109/09273948.2013.808351. Epub 2013 Jul 22.

PMID:
23876164
45.

Association between glaucoma, glaucoma therapies, and erectile dysfunction.

Nathoo NA, Etminan M, Mikelberg FS.

J Glaucoma. 2015 Feb;24(2):135-7. doi: 10.1097/IJG.0b013e3182a0755b.

PMID:
23872619
46.

Risk of acute kidney injury associated with the use of fluoroquinolones.

Bird ST, Etminan M, Brophy JM, Hartzema AG, Delaney JA.

CMAJ. 2013 Jul 9;185(10):E475-82. doi: 10.1503/cmaj.121730. Epub 2013 Jun 3.

47.

Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride.

Bird ST, Brophy JM, Hartzema AG, Delaney JA, Etminan M.

J Urol. 2013 Nov;190(5):1811-4. doi: 10.1016/j.juro.2013.04.132. Epub 2013 May 9.

PMID:
23665270
48.

Oral fluoroquinolones and risk of glaucoma.

Yang L, Etminan M, Mikelberg FS.

J Glaucoma. 2014 Sep;23(7):464-6. doi: 10.1097/IJG.0b013e31829463c1.

PMID:
23632400
49.

Head injury and risk of Parkinson disease: a systematic review and meta-analysis.

Jafari S, Etminan M, Aminzadeh F, Samii A.

Mov Disord. 2013 Aug;28(9):1222-9. doi: 10.1002/mds.25458. Epub 2013 Apr 22. Review.

PMID:
23609436
50.

Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?

Bird ST, Delaney JA, Etminan M, Brophy JM, Hartzema AG.

J Thromb Haemost. 2013 Jun;11(6):1059-68. doi: 10.1111/jth.12224.

Supplemental Content

Loading ...
Support Center